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Background: To evaluate the impact of sampling rate on the predictive capability of con-
tinuous fetal heart rate (FHR) variability (fHRV) monitoring for detecting fetal acidemia
during labor, we tested the performance of the root mean square of successive differ-
ences (RMSSD) in R–R intervals from the ECG when acquired with the sampling rate of
4 Hz currently available in FHR monitors, in comparison to the gold standard of 1000 Hz.
Methods: Near-term ovine fetuses (N = 9) were chronically prepared with precordial elec-
trodes for recording ECG, vascular catheters for blood sampling, and an umbilical cord
occluder. For 1 min every 2.5 min, animals underwent mild partial umbilical cord occlu-
sions (UCO)×1 h, moderate partial UCO×1 h, then complete UCO×2 h, or until arterial
pH reached <7.00. Arterial blood samples were drawn at baseline and every 20 min during
the UCO series. RMSSD was calculated continuously in 5 min windows using an auto-
mated, standardized system (CIMVA.com). Results are presented as mean±SEM with
significance assumed for p<0.05.
Results: Repetitive UCO resulted in pH decreasing from 7.35±0.01 to 7.00±0.03. In
all nine animals, RMSSD increased from 16.7±1.0 ms at baseline to 44.4±2.3 ms,
70±15 min prior to reaching the pH nadir when sampled at 1000 Hz. When sampled at
4 Hz, RMSSD at baseline measured 36.1±6.0 ms and showed no significant increase dur-
ing the UCO series until the pH nadir was reached. Consequently, early detection of severe
hypoxic-acidemia would have been missed in all fetuses.
Conclusion:RMSSD as a measure of fHRV when calculated from FHR sampled at 1000 Hz
allowed for the early detection of worsening hypoxic-acidemia in each fetus. However, when
calculated at the low sampling rate of 4 Hz used clinically, RMSSD remained unchanged
until terminally when the nadir pH was reached. For early detection of fetal acidemia during
labor, more sensitive means of acquiring FHR are therefore recommended than currently
deployed, e.g., trans-abdominal fetal ECG.
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INTRODUCTION
There is an urgent need to identify early signs of fetal acidemia
during labor because severe acidemia is associated with increased
risk of lasting neurological deficits and current diagnostic pro-
cedures are suboptimal (1–3). Variations in fetal vagal activity
can be measured by monitoring fetal heart rate (FHR) variabil-
ity (fHRV) (4, 5). FHR and fHRV are regulated by a complex
interplay of the parasympathetic and sympathetic nervous sys-
tems accounting for the baseline FHR as well as short-term and
long-term fHRV, which show linear and non-linear properties (6).
These fHRV properties are differentially affected by fetal acidemia
(7–9).
One pivotal measure of fHRV is the RMSSD, the root mean
square of the successive differences of R–R intervals in the
ECG (10). Changes in RMSSD reflect modulation of fHRV by
parasympathetic (vagal) activity on a beat-to-beat time scale and
are more precise in capturing vagal activity than the current short-
term FHR variation measures used clinically in electronic FHR
monitoring (EFM) (11). However, this precision depends on the
sampling rate of the ECG signal from which the R–R intervals and
the subsequent fHRV are derived (10).
We have shown that RMSSD is a measure of the matura-
tion of the vagal branch of the autonomic nervous system and
that RMSSD is reduced by atropine (a cholinergic antagonist) in
fetal sheep near-term (5, 7). RMSSD also increases during severe
fetal acidemia (pH ~7.09) induced by 4 min umbilical cord occlu-
sions (UCO) 30 min apart in near-term fetal sheep (7). Therefore,
RMSSD is a potential marker for worsening acidemia.

























































Durosier et al. FHRV sampling rate to detect acidemia
In the present study, we aimed at further evaluating the
impact of fetal ECG sampling rate on the benefit of continu-
ous fHRV monitoring in predicting fetal acidemia. We tested
the performance of RMSSD as a measure of fHRV and change
with worsening fetal acidemia when acquired with the sampling
rate of 4 Hz currently available in FHR monitors, in compari-
son to the gold standard of 1000 Hz. Based on evidence from
animal and human clinical studies, we propose that longitudi-
nal fHRV monitoring during labor will allow us to improve early




Nine near-term ovine fetuses [123± 2 days gestational age (GA),
normal ovine gestation is 145 days] of mixed breed were surgi-
cally instrumented. The anesthetic and surgical procedures and
postoperative care of the animals have been previously described
(3, 12). Briefly, polyvinyl catheters were placed in the right and
left brachiocephalic arteries, the cephalic vein, and the amniotic
cavity. Stainless steel electrodes were sewn onto the fetal chest to
monitor the electrocardiogram (EKG). A polyvinyl catheter was
also placed in the maternal femoral vein. In addition, an inflat-
able silicon rubber cuff (In vivo Metric, Healdsburg, CA, USA)
for UCO was placed around the proximal portion of the umbil-
ical cord and secured to the abdominal skin. Antibiotics were
administered intravenously to the mother (0.2 g trimethoprim
and 1.2 g sulfadoxine, Schering Canada Inc., Pointe-Claire, QC,
Canada) and the fetus and into the amniotic cavity (one mil-
lion IU penicillin G sodium, Pharmaceutical Partners of Canada,
Richmond Hill, ON, Canada). Amniotic fluid lost during surgery
was replaced with warm saline. The uterus and abdominal wall
incisions were sutured in layers and the catheters exteriorized
through the maternal flank and secured to the back of the ewe
in a plastic pouch.
Postoperatively, animals were allowed 4 days to recover prior to
experimentation and daily antibiotic administration was contin-
ued. Arterial blood was sampled for evaluation of maternal and
fetal condition and catheters were flushed with heparinized saline
to maintain patency. Animals were 129± 1 days GA on the first
day of experimental study. Animal care followed the guidelines of
the Canadian Council on Animal Care and was approved by the
University of Western Ontario Council on Animal Care.
EXPERIMENTAL PROCEDURE
Fetal animals were studied over a ~6-h period. After a 1–2 h base-
line control period, all animals underwent mild, moderate, and
severe series of repetitive UCOs by graduated inflation of the
occluder cuff with a saline solution. During the first hour following
the baseline period, mild variable FHR decelerations were elicited
with a partial UCO for 1 min duration every 2.5 min, with the goal
of decreasing FHR by ~30 bpm, corresponding to an ~50% reduc-
tion in umbilical blood flow (13, 14). During the second hour,
moderate variable FHR decelerations were elicited with increased
partial UCO for 1 min duration every 2.5 min with the goal of
decreasing FHR by ~60 bpm, corresponding to a ~75% reduc-
tion in umbilical blood flow (14). Animals then underwent severe
variable FHR decelerations with complete UCO for 1 min dura-
tion every 2.5 min until the targeted fetal arterial pH of <7.0 was
detected or 2 h of severe UCO had been carried out, at which
point the repetitive UCOs were terminated. All animals were then
allowed to recover for 48 h following the last UCO. Fetal arterial
blood samples were drawn at baseline, at the end of the first UCO
of each series (mild, moderate, severe), and at 20 min intervals
(between UCOs) throughout each of the series, as well as at 1, 24,
and 48 h of post-insult recovery. For each UCO series blood gas
sample and the 24 h recovery sample, 0.7 ml of fetal blood was
withdrawn, while 4 ml of fetal blood was withdrawn at baseline,
at pH nadir <7.00, and at 1 and 48 h of recovery. The amounts
of blood withdrawn were documented for each fetus and replaced
with an equivalent volume of maternal blood at the end of day 1
of study.
All blood samples were analyzed for blood gas values, pH, glu-
cose, and lactate with an ABL-725 blood gas analyzer (Radiometer
Medical, Copenhagen, Denmark) with temperature corrected to
39.0°C. Plasma from the 4 ml blood samples was frozen and stored
for cytokine analysis, and will be reported separately.
After the 48 h recovery blood sample, the ewe and the fetus
were killed by an overdose of barbiturate (30 mg sodium pento-
barbital IV, MTC Pharmaceuticals, Cambridge, ON, Canada). A
post mortem was carried out during which fetal sex and weight
were determined and the location and function of the umbilical
occluder were confirmed.
DATA ACQUISITION AND ANALYSIS
A computerized data acquisition system was used to record fetal
arterial and amniotic pressures and ECG, which were monitored
continuously throughout the baseline and UCO series (15). Arter-
ial and amniotic pressures were measured using Statham pressure
transducers (P23 ID; Gould Inc.,Oxnard, CA,USA). Arterial blood
pressure (ABP) was determined as the difference between instan-
taneous values of arterial and amniotic pressures. A PowerLab
system was used for data acquisition and analysis (Chart 7 for
Windows, AD Instruments Pty Ltd., Castle Hill, NSW, Australia).
Pressures and ECG were recorded and digitized at 1000 Hz for
further study. For ECG, a 60 Hz notch filter was applied. FHR
was additionally triggered and calculated in real time from arterial
pressure systolic peaks.
Averaged values of FHR and ABP were calculated from artifact-
free recordings of 1 h of baseline, between and during each consec-
utive variable FHR deceleration induced by UCO (mild, moderate,
severe), as reported (16).
R–R intervals sequence was originally generated from ECG
sampled at 1000 Hz. For simulation of the 4 Hz sampling rate,
the R–R intervals sequence was interpolated at 4 Hz. RMSSD
was calculated from the 1000 and 4 Hz sampled R–R intervals
continuously in 5 min windows overlapping by 2.5 min using
an automated and standardized CIMVA.com system (Figure 1).
Next, average RMSSD values were determined for the 1 h base-
line period and each 20 min interval from the UCO experimental
period and correlated to the time-matched pH, lactate, and base
excess (BE) values. Accordingly, each 20 min interval included ~8
UCO-induced FHR decelerations and the intervening recovery
periods.
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FIGURE 1 | A representative example of the CIMVA fHRV analysis of RMSSD at (top) 1000Hz and (bottom) 4Hz. Note the gradual rise of RMSSD with
worsening acidemia (pH decreasing) and an overestimation of RMSSD at baseline in 4 Hz sampled fHRV. Mild, mod and sev=mild, moderate, and severe UCO
series, respectively.
STATISTICAL ANALYSIS
Normal data distribution was tested using the Kolmogorov–
Smirnov test followed by parametric or non-parametric tests, as
appropriate. The pH measurements and the temporal change in
RMSSD values versus baseline for the 1000 and 4 Hz sampling rates
were compared by one-way repeated measures ANOVA followed

























































Durosier et al. FHRV sampling rate to detect acidemia
by Holm–Sidak or one-way repeated measures ANOVA on ranks
(Friedman) followed by correction for multiple comparisons
(Dunn’s method) as applicable.
All values are expressed as means± SEM with statistical sig-
nificance assumed for p< 0.05. Pearson or Spearman correlation
analysis was performed as appropriate, and R values are presented
where p< 0.05 (SPSS 19; IBM, Armonk, NY, USA).
RESULTS
Baseline fetal arterial pH (7.35± 0.01) as well as FHR
(159± 5 bpm) and ABP (44± 2 mmHg) were within physiological
range.
Repetitive fetal UCO resulted in development of marked acido-
sis with arterial pH decreasing from 7.35± 0.01 to 7.00± 0.03 and
BE from 1.6± 0.7 to −13.6± 1.1 mEq/l by the end of the UCO
study (both p< 0.01). ABP increased on average to 75± 3 mm
Hg during each UCO versus 54± 2 mm Hg between each UCO
(p< 0.05). FHR deceleration depth averaged 66± 6 bpm decreas-
ing to 94± 6 bpm during each UCO versus 159± 3 bpm between
each UCO (p< 0.05).
The changes in RMSSD with the repetitive UCO are summa-
rized in Figure 2. When sampled at 1000 Hz, baseline RMSSD
measured 16.7± 1.0 ms with all animals, then increased to
44.4± 2.3 ms during the repetitive UCO 70± 15 min prior to
reaching the pH nadir (p< 0.01). This increase was evident 20 min
into severe UCO series. All subsequent measurements of RMSSD
until the UCO were stopped showed similar increases compared
to baseline RMSSD values (Figure 2, all p< 0.01).
When sampled at 4 Hz, baseline RMSSD was found to mea-
sure 36.1± 6.0 ms. Albeit higher on average, this value was not
statistically significantly different from the 1000 Hz sampled base-
line measurement (Wilcoxon signed rank p= 0.3). During the
repetitive UCO, RMSSD showed no definite increase in five of
the nine fetuses. In the remaining four fetuses an increase was
observed, but only at the time of reaching the pH nadir. Moreover,
their RMSSD increase occurred 100 min into the severe UCO series
with RMSSD measuring 85.9± 9.5 ms (p< 0.01) (Figure 2).
DISCUSSION
In the present study, RMSSD increased early with worsening
hypoxic-acidemia in each fetus when sampled at 1000 Hz. This is in
line with previous observations in fetal sheep near-term undergo-
ing repetitive UCO and giving rise to worsening hypoxic-acidemia
(7). However, when fetal ECG was instead sampled at 4 Hz simu-
lating the low sampling rate for fHRV used clinically in electronic
FHR monitors, RMSSD was not significantly changed in five of
the fetal sheep and only increased terminally with severe hypoxic-
acidemia in the other four animals. The methodological reason
for this finding is overestimation of fHRV due to undersampling
(17, 18). As pointed out by Merri et al., this overestimation may
be further impacted by the degree of the biological variability
itself introducing an additional confounder in the fHRV measures
derived from low sampled FHR data.
There are several reasons why FHR monitoring fails to detect
fetal hypoxic-acidemia as presently used clinically. First, limited
information can be derived by visual analysis of the FHR pat-
tern and uterine contractions. Second, present technology for
the detection of fetal heart bioelectric events is limited by poor
recording of the true bioelectric signal. Trans-abdominal Doppler
probes operate on averaged biophysical signals, and scalp elec-
trodes, either filtered or sampled at low frequency, detect a robust
but smoothed QRS signal (19). This results in loss of the infor-
mation embedded in fHRV (5, 7). The time scale of subtle fHRV
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FIGURE 2 | FHRV analysis of RMSSD changes during worsening acidemia
(black) at 1000Hz and (gray) 4Hz sampling rates. Animals reached pH
nadir <7.00 between the time points “severe UCO 40 min” and “severe UCO
100 min.” Accordingly, sample sizes of these time points were lower where
indicated. For other time points, N = 9. Mean±SEM. *p< 0.05 versus
baseline for 1000 Hz sampled fHRV; # versus baseline for 4 Hz sampled fHRV.
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the QRS complex within <1 ms (6, 20, 21). Our approach and
findings in the fetal sheep model are echoed and supported by
the recently published prospective study of human fHRV (18).
The commercial FHR acquisition software of a conventional car-
diotocogram monitor used in that study sampled FHR derived
from the Doppler signal every 2.5 s. The researchers modified
this algorithm to read the FHR every 0.5 s (corresponding to
2 Hz, still twice as low as the sampling rate simulated in the
present study), thus somewhat increasing the precision of fHRV
estimation. Despite the still very low fHRV sampling rate, the lin-
ear and non-linear fHRV measures determined from this data
set allowed the authors to detect differences between the fHRV
of the intrauterine growth-restricted fetuses (IUGR) compared
to the healthy fetuses. Notably, the authors reported no differ-
ence in the high frequency power spectrum estimates of fHRV
between the groups. This is consistent with the main finding of
this study that low HRV sampling rates likely overestimate HRV,
thus obscuring the true change in HRV due to a pathophysiological
state.
Thus, for earlier detection of fetal acidemia during labor as
herein shown with RMSSD as a measure of fHRV, more sensi-
tive means of acquiring FHR are recommended than currently
deployed in EFM. Candidates for alternative means of fetal assess-
ment for detecting the onset of hypoxic-acidemia include trans-
abdominal ECG, already used at the bedside in some jurisdictions,
or experimental approaches involving fetal EEG during labor (22–
24). Fetal scalp ECG could also be sampled at 1000 Hz, thus
permitting true fHRV analyses such as presented here.
Limitations of this study are its small sample size and focus
on one particular fHRV measure reflecting vagal modulations of
fHRV, the RMSSD. Larger prospective studies in fetal sheep model
and human clinical prospective trials of FHR monitoring during
labor are needed to provide high resolution R–R data sets with
correlated clinical outcomes such as pH and BE at birth. Such data
sets could then be studied with a more encompassing panel of
fHRV measures to validate their usefulness in intrapartum FHR
monitoring for early detection of fetal acidemia. First steps in this
direction have been made with respect to sample size, but not
yet with respect to the R–R temporal resolution, i.e., sampling
rate (25).
SIGNIFICANCE AND NOVELTY
Continuous beat-to-beat fHRV monitoring capable of detecting
vagal activation due to fetal acidemia may be a useful tool for early
detection of hypoxic-acidemia near term.
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